Chemokine Therapeutics Announces New Directors

19-Dec-2007

Chemokine Therapeutics Corp. announced that Brian Kuhn, Bernard Byrd, George Kowalchuk and Reza Bahadori have joined the Board of Directors. They will fill vacancies created by the resignations of C. Richard Piazza, Michael Evans, John Osth and Matthias Kurth. The new directors will serve until such time as the shareholders have the opportunity to vote on a new Board of Directors at the 2008 Annual General Shareholders Meeting. Dr. Hassan Salari, founder of the Company, has been appointed Chairman by the new Board of Directors.

Mr. Brian Kuhn is an experienced businessman with over 20 years in trading securities actively through his fund, Lakeside Investments. For the past 15 years Mr. Kuhn has also provided consulting and review of public offerings for Broidy Capital (a private equity fund based out of Los Angeles, CA). Mr. Kuhn obtained his CPA from the California State Board of Accountancy in 1990. He spent four years at Arthur Andersen & Co. before leaving to start his own firm. He has extensive accounting experience and has participated in a number of public as well as private security investments. Mr. Kuhn is involved in several start-up businesses and charity organizations in Southern California.

Mr. Bernard Byrd is an entrepreneur with more than 20 years experience in a variety of business ventures. Currently Mr. Byrd is the President and CEO of Secure EDI, a healthcare IT company that operates in the US and in Puerto Rico as Inmediata. Previously, Mr. Byrd served as Chairman of HRAmerica, a company which he founded and served as its Chairman and CEO until April 2005. He was President of Human Resource ONE, a company that he founded, sold and brought public as NovaCare Employee Services in 1997. In the past Mr. Byrd also served as VP of Finance for Your Staff, Inc. and CFO of Staffing Services, Inc. Mr. Byrd graduated from California State Polytechnic University and holds a degree in Business Administration. Mr. Byrd also serves on the Board of Trustees for Speedway Children's Charities.

Mr. George Kowalchuk is a retired businessman and investor with thirty years of investment experience related to biotechnology companies.

Mr. Reza Bahadori is a Senior Financial Advisor at Paulson Investment Company. Mr. Bahadori has been involved in a number of transactions for various healthcare and technology companies. He is an active member of RIBA (Regional Investment Bankers Association) and is a Registered Investment Advisor with FINRA (formally NASD). He has extensive knowledge of financial and investment banking.

https://www.bionity.com/en/news/75892/chemokine-therapeutics-announces-new-directors.html